Process / pipelineOncology and Cancer Outcomes
EORTC QLQ-C30
The EORTC QLQ-C30 is the most widely used international instrument for assessing quality of life in cancer patients. Developed by the European Organisation for Research and Treatment of Cancer in 1993, it measures physical, emotional, cognitive, and social functioning alongside cancer-specific symptoms and financial impact, making it the standard outcome measure in oncology clinical trials and patient care.
Open in MethodMindSoonVideoSoon
Read the full method
Members only
Sign inSign in with a free account to read this section.
Sources
- Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., ... & Takeda, F. (1993). The European Organisation for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85(5), 365-376. DOI: 10.1093/jnci/85.5.365 ↗
- Fayers, P. M., & Bottomley, A. (2001). Quality of life research within the EORTC-the EORTC QLQ-C30. European Journal of Cancer, 38(4), 427-431. DOI: 10.1016/S0959-8049(02)00130-8 ↗
- Cella, D. (1998). The Functional Assessment of Cancer Therapy Scale: Development and validation. Journal of Clin Oncol, 11(3), 570-579. link ↗